Published in Am J Physiol Endocrinol Metab on February 03, 2009
Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci (2011) 3.15
Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol (2010) 2.84
Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol (2011) 1.53
The neurobiology of food intake in an obesogenic environment. Proc Nutr Soc (2012) 1.43
Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol (2011) 1.38
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. Br J Pharmacol (2010) 1.32
Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab (2011) 1.26
Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats. PLoS One (2012) 1.17
Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin. Physiol Behav (2011) 1.13
Diet-induced adaptation of vagal afferent function. J Physiol (2011) 1.08
Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol (2013) 1.00
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype. Am J Physiol Gastrointest Liver Physiol (2010) 0.99
The role of gastrointestinal vagal afferent fibres in obesity. J Physiol (2014) 0.97
Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol (2015) 0.97
High fat diet attenuates glucose-dependent facilitation of 5-HT3 -mediated responses in rat gastric vagal afferents. J Physiol (2015) 0.93
PPARγ in vagal neurons regulates high-fat diet induced thermogenesis. Cell Metab (2014) 0.90
Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose. Annu Rev Nutr (2014) 0.89
Differential effects of high-fat-diet rich in lard oil or soybean oil on osteopontin expression and inflammation of adipose tissue in diet-induced obese rats. Eur J Nutr (2012) 0.89
Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density. Physiol Behav (2011) 0.88
Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol (2014) 0.86
Exposure to a high fat diet during the perinatal period alters vagal motoneurone excitability, even in the absence of obesity. J Physiol (2014) 0.86
Influence of a long-term high-fat diet on ghrelin secretion and ghrelin-induced food intake in rats. Regul Pept (2011) 0.84
Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol Behav (2014) 0.84
Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4. Diabetes (2013) 0.83
Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology. Front Neurosci (2015) 0.82
Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology. Adv Nutr (2014) 0.80
Mechanism of hyperphagia contributing to obesity in brain-derived neurotrophic factor knockout mice. Neuroscience (2012) 0.79
Effect of ghrelin receptor antagonist on meal patterns in cholecystokinin type 1 receptor null mice. Physiol Behav (2011) 0.78
Vagal plasticity the key to obesity. Mol Metab (2014) 0.78
High fat diet and body weight have different effects on cannabinoid CB(1) receptor expression in rat nodose ganglia. Auton Neurosci (2013) 0.77
Early postnatal overnutrition: potential roles of gastrointestinal vagal afferents and brain-derived neurotrophic factor. Physiol Behav (2012) 0.77
Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology. BMC Gastroenterol (2016) 0.76
Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms. J Physiol (2014) 0.76
Evaluation of the synuclein-γ (SNCG) gene as a PPARγ target in murine adipocytes, dorsal root ganglia somatosensory neurons, and human adipose tissue. PLoS One (2015) 0.76
Peripheral Pathways in the Food-Intake Control towards the Adipose-Intestinal Missing Link. Int J Endocrinol (2013) 0.75
The effects of bariatric surgery: will understanding its mechanism render the knife unnecessary? Expert Rev Gastroenterol Hepatol (2013) 0.75
Inhibitory neurotransmission regulates vagal efferent activity and gastric motility. Exp Biol Med (Maywood) (2016) 0.75
Prebiotic milk oligosaccharides prevent development of obese phenotype, impairment of gut permeability, and microbial dysbiosis in high fat-fed mice. Am J Physiol Gastrointest Liver Physiol (2017) 0.75
Bugs, guts and brains, and the regulation of food intake and body weight. Int J Obes Suppl (2016) 0.75
Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (1999) 17.72
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics (2006) 5.04
Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest (2005) 3.92
The hormonal control of food intake. Cell (2007) 3.61
The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology (2002) 3.17
Absence of ghrelin protects against early-onset obesity. J Clin Invest (2005) 2.53
A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci (2002) 2.52
Gastrointestinal hormones and food intake. Gastroenterology (2005) 2.00
Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J Neurosci (2004) 1.79
The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology (2005) 1.58
Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci (2006) 1.56
Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. Am J Physiol Gastrointest Liver Physiol (2006) 1.46
Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk. Curr Hypertens Rep (2008) 1.27
Mechanisms of CCK signaling from gut to brain. Curr Opin Pharmacol (2007) 1.25
Adaptation to a high-fat diet leads to hyperphagia and diminished sensitivity to cholecystokinin in rats. J Nutr (2005) 1.25
CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet. Physiol Behav (2007) 1.23
Dysregulation of the endocannabinoid system in obesity. J Neuroendocrinol (2008) 1.22
Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors. Am J Physiol Regul Integr Comp Physiol (2007) 1.18
Characterization of Tusc5, an adipocyte gene co-expressed in peripheral neurons. Mol Cell Endocrinol (2007) 1.03
Altered sympathetic activity during development of diet-induced obesity in rat. Am J Physiol (1983) 0.97
Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway. Endocrinology (2007) 0.92
Adaptation of lipid-induced satiation is not dependent on caloric density in rats. Physiol Behav (2007) 0.92
Regulation of GH secretagogue receptor gene expression in the rat nodose ganglion. J Endocrinol (2007) 0.87
Metabolic features of diet-induced obesity without hyperphagia in young rats. Am J Physiol (1986) 0.84
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab (2007) 6.83
The human serum metabolome. PLoS One (2011) 5.55
Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology (2004) 4.25
Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci U S A (2005) 4.07
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases. Biochem Pharmacol (2002) 2.86
Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol (2010) 2.84
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension (2005) 2.76
A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem (2003) 2.69
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest (2011) 2.68
Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J Am Soc Nephrol (2004) 2.59
Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab (2009) 2.58
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res (2006) 2.33
Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One (2010) 2.14
Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci (2008) 2.09
Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology (2010) 1.96
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem (2006) 1.95
Lipid mediators of insulin resistance. Nutr Rev (2007) 1.82
Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res (2012) 1.79
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Hum Mol Genet (2006) 1.74
Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res (2008) 1.71
An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol (2005) 1.59
Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab (2013) 1.58
The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology (2010) 1.47
Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res (2009) 1.42
The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol (2011) 1.41
Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem (2004) 1.39
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats. Clin Sci (Lond) (2009) 1.34
Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB J (2008) 1.30
Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab (2011) 1.26
Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS One (2011) 1.25
CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet. Physiol Behav (2007) 1.23
Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem (2005) 1.22
Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase. Biochemistry (2005) 1.21
Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery. Anal Bioanal Chem (2012) 1.18
Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats. PLoS One (2012) 1.17
In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea. Drug Metab Dispos (2003) 1.14
Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach. J Neurosci (2008) 1.14
Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands. Am J Physiol Regul Integr Comp Physiol (2007) 1.14
Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin. Physiol Behav (2011) 1.13
Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers. J Lipid Res (2012) 1.12
Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology (2002) 1.12
imDEV: a graphical user interface to R multivariate analysis tools in Microsoft Excel. Bioinformatics (2012) 1.12
Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS One (2012) 1.09
Characterization of mice lacking the gene for cholecystokinin. Am J Physiol Regul Integr Comp Physiol (2007) 1.09
Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutr (2012) 1.08
Leucine and protein metabolism in obese Zucker rats. PLoS One (2013) 1.07
Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells. J Am Coll Nutr (2003) 1.06
Peptidyl-urea based inhibitors of soluble epoxide hydrolases. Bioorg Med Chem Lett (2006) 1.05
IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal. Circ Res (2012) 1.04
Characterization of Tusc5, an adipocyte gene co-expressed in peripheral neurons. Mol Cell Endocrinol (2007) 1.03
Impact of circulating esterified eicosanoids and other oxylipins on endothelial function. Curr Atheroscler Rep (2009) 1.03
Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins. Prostaglandins Leukot Essent Fatty Acids (2008) 1.02
Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity. Am J Physiol Endocrinol Metab (2013) 1.02
Ligand-induced 5-HT3 receptor internalization in enteric neurons in rat ileum. Gastroenterology (2006) 1.00
Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat. Endocrinology (2007) 0.99
Central Fos expression and conditioned flavor avoidance in rats following intragastric administration of bitter taste receptor ligands. Am J Physiol Regul Integr Comp Physiol (2008) 0.98
Gamma-synuclein is an adipocyte-neuron gene coordinately expressed with leptin and increased in human obesity. J Nutr (2008) 0.97
Genetic contribution of the leukotriene pathway to coronary artery disease. Hum Genet (2011) 0.96
Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2011) 0.95
12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis (2011) 0.95
Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake. Am J Physiol Regul Integr Comp Physiol (2007) 0.94
Development of metabolically stable inhibitors of Mammalian microsomal epoxide hydrolase. Chem Res Toxicol (2008) 0.93
Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obes Res (2004) 0.93
Activation of hindbrain neurons in response to gastrointestinal lipid is attenuated by high fat, high energy diets in mice prone to diet-induced obesity. Brain Res (2008) 0.93
Increased lipolysis and altered lipid homeostasis protect γ-synuclein-null mutant mice from diet-induced obesity. Proc Natl Acad Sci U S A (2012) 0.93
Decreased expression of adipose CD36 and FATP1 are associated with increased plasma non-esterified fatty acids during prolonged fasting in northern elephant seal pups (Mirounga angustirostris). J Exp Biol (2012) 0.90
Protein hydrolysate-induced cholecystokinin secretion from enteroendocrine cells is indirectly mediated by the intestinal oligopeptide transporter PepT1. Am J Physiol Gastrointest Liver Physiol (2011) 0.90
Inflammatory phenotyping identifies CD11d as a gene markedly induced in white adipose tissue in obese rodents and women. J Nutr (2011) 0.90
Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. BMC Med Genomics (2010) 0.89
Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor-mediated pathway to inhibit gastric motor function in the rat. J Physiol (2003) 0.89
Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res (2011) 0.89
Chylomicron components mediate intestinal lipid-induced inhibition of gastric motor function. Am J Physiol Gastrointest Liver Physiol (2002) 0.89
Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice. Am J Respir Cell Mol Biol (2014) 0.89
Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology (2010) 0.89
Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats. Nutr Neurosci (2008) 0.89
Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition. J Pharmacol Exp Ther (2005) 0.89
Fatty acid composition of liver, adipose tissue, spleen, and heart of mice fed diets containing t10, c12-, and c9, t11-conjugated linoleic acid. Prostaglandins Leukot Essent Fatty Acids (2006) 0.87
Muscle uncoupling protein 3 overexpression mimics endurance training and reduces circulating biomarkers of incomplete β-oxidation. FASEB J (2013) 0.87
Long-chain fatty acid combustion rate is associated with unique metabolite profiles in skeletal muscle mitochondria. PLoS One (2010) 0.87
A dairy-based high calcium diet improves glucose homeostasis and reduces steatosis in the context of preexisting obesity. Obesity (Silver Spring) (2013) 0.87
Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice. Metabolomics (2007) 0.86
Methylmalonic acid quantification in low serum volumes by UPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.85
Web-enabled and improved software tools and data are needed to measure nutrient intakes and physical activity for personalized health research. J Nutr (2010) 0.84
Vagal afferents are essential for maximal resection-induced intestinal adaptive growth in orally fed rats. Am J Physiol Regul Integr Comp Physiol (2006) 0.83
ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation. J Lipid Res (2011) 0.83
Molecular Characterization of the Tumor Suppressor Candidate 5 Gene: Regulation by PPARgamma and Identification of TUSC5 Coding Variants in Lean and Obese Humans. PPAR Res (2010) 0.83